Pfizer Trades Above 50-Day Average for a Month: Time to Buy?

Key Takeaways PFE has traded above its 50-day SMA since the end of May, marking a short-term bullish trend. Pfizer's new products and Seagen deal are driving growth despite falling COVID sales and patent expirations. PFE trades below its 5-year average P/E, offering value amid high dividends and cost-cutting efforts.Pfizer (PFE) has reached a significant support level, making it an attractive option for investors from a technical standpoint. Since the end of May, the stock has been trading above its 50-da ...